Your browser doesn't support javascript.
loading
Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus.
Sotelo, René; Sayegh, Aref S; Medina, Luis G; Perez, Laura C; La Riva, Anibal; Eppler, Michael B; Gaona, José; Tobias-Machado, Marcos; Spiess, Philippe E; Pettaway, Curtis A; Lima Pompeo, Antonio Carlos; Lima Mattos, Pablo Aloisio; Wilson, Timothy G; Villoldo, Gustavo M; Chung, Eric; Samaniego, Aldo; Ornellas, Antonio Augusto; Pinheiro, Vladimir; Brazão, Eder S; Subira-Rios, David; Koifman, Leandro; Zequi, Stênio de Cassio; Pontillo Z, Humberto M; Rodrigues Calixto, José de Ribamar; Campos Silva, Rafael; Smithers, B Mark; Garzon, Simone; Haase, Oliver; Sommariva, Antonio; Fruscio, Robert; Martins, Francisco; de Oliveira, Pedro S; Levi Sandri, Giovanni Battista; Clementi, Marco; Astigueta, Juan; Metwally, Islam H; Bharathan, Rasiah; Jindal, Tarun; Nakamura, Yasuhiro; Abdel Mageed, Hisham; Jeevarajan, Sakthiushadevi; Rodriguez Lay, Ramón; García-Perdomo, Herney Andrés; Rodríguez González, Omaira; Ghodoussipour, Saum; Gill, Inderbir; Cacciamani, Giovanni E.
Afiliación
  • Sotelo R; Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Sayegh AS; Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Medina LG; Department of Surgery, MedStar Franklin Square Medical Center, Baltimore, Maryland, USA.
  • Perez LC; Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • La Riva A; Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Eppler MB; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Gaona J; Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Tobias-Machado M; Department of General Surgery, Digestive Disease & Surgery Institute, Cleveland Clinic Foundation, Cleveland, Ohio, USA.
  • Spiess PE; Catherine and Joseph Aresty Department of Urology, University of Southern California Institute of Urology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Pettaway CA; Universidad de Santander, Instituto Uromédica, Bucaramanga, Colombia.
  • Lima Pompeo AC; Department of Urology, Instituto do Câncer Arnaldo Vieira de Carvalho, São Paulo, Brazil.
  • Lima Mattos PA; Department of Genitourinary Oncology and Tumor Biology, Moffitt Cancer Center, Tampa, Florida, USA.
  • Wilson TG; The University of Texas, M.D. Anderson Cancer Center, Houston, Texas, USA.
  • Villoldo GM; Department of Urology, Faculdade de Medicina do ABC, São Paulo, Brazil.
  • Chung E; Department of Urology, Associação Piauiense de Combate ao Câncer, Teresina, Piauí, Brazil.
  • Samaniego A; Department of Urology, Providence St. John's Cancer Institute, Santa Monica, California, USA.
  • Ornellas AA; Department of Urology, Instituto Alexander Fleming, Buenos Aires, Argentina.
  • Pinheiro V; Department of Urology, Princess Alexandra Hospital, University of Queensland, Brisbane, Queensland, Australia.
  • Brazão ES; Department of Urology, Servicio de Urología del Hospital Central del Instituto de Previsión Social, Asunción, Paraguay.
  • Subira-Rios D; Departamento de Urologia, Instituto Nacional do Câncer do Brasil (INCA), Rio de Janeiro, Brazil.
  • Koifman L; Department of Urology, AC Camargo Cancer Center, São Paulo, Brazil.
  • Zequi SC; Department of Urology, AC Camargo Cancer Center, São Paulo, Brazil.
  • Pontillo Z HM; Department of Urology, Gregorio Marañon Universitary Hospital, Madrid, Spain.
  • Rodrigues Calixto JR; Serviço de Urologia, Hospital Municipal Souza Aguiar, Rio de Janeiro, Rio de Janeiro, Brazil.
  • Campos Silva R; Department of Urology, AC Camargo Cancer Center-São Paulo, São Paulo, Brazil.
  • Smithers BM; Department of Urology, National Institute for Science and Technology in Oncogenomics and Therapeutic Innovation, São Paulo, Brazil.
  • Garzon S; Graduate School of Urology, Escola Paulista de Medicina-Universidade Federal de São Paulo, São Paulo, Brazil.
  • Haase O; Department of Urology, Sant Jaume of Calella Hospital, Barcelona, Spain.
  • Sommariva A; Department of Medicine II, Federal University of Maranhão, São Luís, Massachusetts, Brazil.
  • Fruscio R; Department of Urology, Hospital Universitário Presidente Dutra-HUPD/UFMA, São Luís, Maranhão, Brazil.
  • Martins F; University of Queensland, Queensland Melanoma Project, Princess Alexandra Hospital, Brisbane, Queensland, Australia.
  • de Oliveira PS; Department of Surgery, Dentistry, Pediatrics, and Gynecology, University of Verona, Verona, Italy.
  • Levi Sandri GB; Department of Surgery, University Medicine Berlin-Charité, Berlin, Germany.
  • Clementi M; Veneto Institute of Oncology Institute Oncology Veneto, Istituto Di Ricovero e Cura a Carattere Scientifico, Padova, Italy.
  • Astigueta J; Department of Medicine and Surgery, University of Milan Bicocca, Azienda Socio Sanitaria Territoriale Monza, Italy.
  • Metwally IH; Department of Urology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal.
  • Bharathan R; Department of Urology, Centro Hospitalar Universitário Lisboa Norte, Hospital de Santa Maria, Lisbon, Portugal.
  • Jindal T; Department of Surgery, ASL Frosinone, Frosinone, Italy.
  • Nakamura Y; Department of Medicine, Health and Life, University of L'Aquila, L'Aquila, AQ, Italy.
  • Abdel Mageed H; Department of Urology, Universidad Privada Antenor Orrego, Trujillo, Perú.
  • Jeevarajan S; Surgical Oncology Department, Oncology Center Mansoura University (OCMU), Mansoura, Egypt.
  • Rodriguez Lay R; Department of Gynaecological Oncology, Medical University of Vienna, Vienna, Austria.
  • García-Perdomo HA; Department of Uro-oncology, Narayana Super Speciality Hospital, Howrah, India.
  • Rodríguez González O; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
  • Ghodoussipour S; Surgical Oncology Department, National Cancer Institute Cairo University, Cairo, Egypt.
  • Gill I; Department of Surgical Oncology, Regional Cancer Centre, Kanchipuram, Tamil Nadu, India.
  • Cacciamani GE; Clinic Urology Service, Complejo Hospitalario Metropolitano, Madrid, Panama.
BJS Open ; 8(4)2024 Jul 02.
Article en En | MEDLINE | ID: mdl-38987232
ABSTRACT

BACKGROUND:

Inguinal lymph node dissection plays an important role in the management of melanoma, penile and vulval cancer. Inguinal lymph node dissection is associated with various intraoperative and postoperative complications with significant heterogeneity in classification and reporting. This lack of standardization challenges efforts to study and report inguinal lymph node dissection outcomes. The aim of this study was to devise a system to standardize the classification and reporting of inguinal lymph node dissection perioperative complications by creating a worldwide collaborative, the complications and adverse events in lymphadenectomy of the inguinal area (CALI) group.

METHODS:

A modified 3-round Delphi consensus approach surveyed a worldwide group of experts in inguinal lymph node dissection for melanoma, penile and vulval cancer. The group of experts included general surgeons, urologists and oncologists (gynaecological and surgical). The survey assessed expert agreement on inguinal lymph node dissection perioperative complications. Panel interrater agreement and consistency were assessed as the overall percentage agreement and Cronbach's α.

RESULTS:

Forty-seven experienced consultants were enrolled 26 (55.3%) urologists, 11 (23.4%) surgical oncologists, 6 (12.8%) general surgeons and 4 (8.5%) gynaecology oncologists. Based on their expertise, 31 (66%), 10 (21.3%) and 22 (46.8%) of the participants treat penile cancer, vulval cancer and melanoma using inguinal lymph node dissection respectively; 89.4% (42 of 47) agreed with the definitions and inclusion as part of the inguinal lymph node dissection intraoperative complication group, while 93.6% (44 of 47) agreed that postoperative complications should be subclassified into five macrocategories. Unanimous agreement (100%, 37 of 37) was achieved with the final standardized classification system for reporting inguinal lymph node dissection complications in melanoma, vulval cancer and penile cancer.

CONCLUSION:

The complications and adverse events in lymphadenectomy of the inguinal area classification system has been developed as a tool to standardize the assessment and reporting of complications during inguinal lymph node dissection for the treatment of melanoma, vulval and penile cancer.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Pene / Complicaciones Posoperatorias / Neoplasias de la Vulva / Técnica Delphi / Consenso / Conducto Inguinal / Escisión del Ganglio Linfático / Melanoma Límite: Female / Humans / Male Idioma: En Revista: BJS Open Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias del Pene / Complicaciones Posoperatorias / Neoplasias de la Vulva / Técnica Delphi / Consenso / Conducto Inguinal / Escisión del Ganglio Linfático / Melanoma Límite: Female / Humans / Male Idioma: En Revista: BJS Open Año: 2024 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido